Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is a common malignancy arising from the liver with limited 5-year survival. Thus, there is an urgency to explore new treatment methods. Chimeric antigen receptor T (CAR T) cell therapy is a very promising cancer treatment. Though, several groups have investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Li, Su, Sheng, Li, Jia, Yu, Songyang, Gong, Yu, Chen, Changzhou, Hu, Zhiqiang, Huang, Xiaowu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Basic Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988215/
https://www.ncbi.nlm.nih.gov/pubmed/36883998
http://dx.doi.org/10.1097/CJI.0000000000000460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988215/
https://www.ncbi.nlm.nih.gov/pubmed/36883998
http://dx.doi.org/10.1097/CJI.0000000000000460

Ejemplares similares